Efficacy of combined treatment with alendronate (ALN) and eldecalcitol a new active vitamin D analog compared to that of concomitant ALN vitamin D plus calcium treatment in Japanese patients with primary osteoporosis

摘要

SummaryCombined treatment with alendronate and eldecalcitol was found to be more effective in reducing the bone turnover markers and increasing bone mineral density than alendronate treatment with vitamin D3 and calcium supplementation in the osteoporotic patients.